{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T22:28:46Z","timestamp":1783722526583,"version":"3.55.0"},"reference-count":115,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:00:00Z","timestamp":1756425600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.rmed.2025.108333","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T15:08:04Z","timestamp":1756480084000},"page":"108333","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Comorbidities as treatable traits of chronic airway diseases"],"prefix":"10.1016","volume":"248","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4895-9707","authenticated-orcid":false,"given":"Mario","family":"Cazzola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola A.","family":"Hanania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Rogliani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmed.2025.108333_bib1","unstructured":"Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. 2025 Report. Available from:: https:\/\/goldcopd.org\/2025-gold-report\/."},{"issue":"173","key":"10.1016\/j.rmed.2025.108333_bib3","volume":"33","author":"Chalmers","year":"2024","journal-title":"Eur. Respir. Rev."},{"issue":"2","key":"10.1016\/j.rmed.2025.108333_bib4","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1159\/000281880","article-title":"Prevalence of comorbidities in patients with chronic obstructive pulmonary disease","volume":"80","author":"Cazzola","year":"2010","journal-title":"Respiration"},{"issue":"1","key":"10.1016\/j.rmed.2025.108333_bib5","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1183\/09031936.00140310","article-title":"Asthma and comorbid medical illness","volume":"38","author":"Cazzola","year":"2011","journal-title":"Eur. Respir. J."},{"issue":"1","key":"10.1016\/j.rmed.2025.108333_bib6","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/MCP.0b013e32835b113a","article-title":"Comorbidities of asthma: current knowledge and future research needs","volume":"19","author":"Cazzola","year":"2013","journal-title":"Curr. Opin. Pulm. Med."},{"issue":"6","key":"10.1016\/j.rmed.2025.108333_bib7","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1007\/s00592-014-0584-0","article-title":"Diabetes mellitus among outpatients with COPD attending a university hospital","volume":"51","author":"Rogliani","year":"2014","journal-title":"Acta Diabetol."},{"issue":"4","key":"10.1016\/j.rmed.2025.108333_bib8","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1080\/15412555.2018.1464551","article-title":"Chronic obstructive pulmonary disease and stroke","volume":"15","author":"Corlateanu","year":"2018","journal-title":"COPD J. Chronic Obstr. Pulm. Dis."},{"issue":"11","key":"10.1016\/j.rmed.2025.108333_bib9","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/S2213-2600(23)00261-8","article-title":"COPD and multimorbidity: recognising and addressing a syndemic occurrence","volume":"11","author":"Fabbri","year":"2023","journal-title":"Lancet Respir. Med."},{"issue":"10","key":"10.1016\/j.rmed.2025.108333_bib10","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1007\/s40265-024-02086-5","article-title":"Asthma and cardiovascular diseases: navigating mutual pharmacological interferences","volume":"84","author":"Cazzola","year":"2024","journal-title":"Drugs"},{"issue":"6","key":"10.1016\/j.rmed.2025.108333_bib11","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1080\/1744666X.2025.2514607","article-title":"The interplay between asthma and type 2 diabetes mellitus: mutual interactions and therapeutic implications","volume":"21","author":"Cazzola","year":"2025","journal-title":"Expet Rev. Clin. Immunol."},{"key":"10.1016\/j.rmed.2025.108333_bib12","doi-asserted-by":"crossref","DOI":"10.1177\/20406223231171556","article-title":"Cardiovascular diseases or type 2 diabetes mellitus and chronic airway diseases: mutual pharmacological interferences","volume":"14","author":"Cazzola","year":"2023","journal-title":"Ther Adv Chronic Dis"},{"key":"10.1016\/j.rmed.2025.108333_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2021.106572","article-title":"Moving towards a Treatable Traits model of care for the management of obstructive airways diseases","volume":"187","author":"Agusti","year":"2021","journal-title":"Respir. Med."},{"issue":"2","key":"10.1016\/j.rmed.2025.108333_bib14","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1183\/13993003.01359-2015","article-title":"Treatable traits: toward precision medicine of chronic airway diseases","volume":"47","author":"Agusti","year":"2016","journal-title":"Eur. Respir. J."},{"issue":"11","key":"10.1016\/j.rmed.2025.108333_bib15","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1111\/resp.14325","article-title":"Treatable traits in the NOVELTY study","volume":"27","author":"Agust\u00ed","year":"2022","journal-title":"Respirology"},{"issue":"5","key":"10.1016\/j.rmed.2025.108333_bib16","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02058-2018","article-title":"Treatable traits: a new paradigm for 21st century management of chronic airway diseases: treatable traits Down under International Workshop report","volume":"53","author":"McDonald","year":"2019","journal-title":"Eur. Respir. J."},{"issue":"575","key":"10.1016\/j.rmed.2025.108333_bib17","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3399\/bjgp10X502056","article-title":"Chronic disease and comorbidity","volume":"60","author":"Jones","year":"2010","journal-title":"Br. J. Gen. Pract."},{"issue":"1","key":"10.1016\/j.rmed.2025.108333_bib18","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41533-024-00381-y","article-title":"Change is in the air: key questions on the 'Treatable Traits' model for chronic airway diseases in primary care","volume":"34","author":"Agusti","year":"2024","journal-title":"NPJ Prim Care Respir Med"},{"issue":"6","key":"10.1016\/j.rmed.2025.108333_bib19","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.jaci.2024.10.007","article-title":"Upper airway comorbidities of asthma","volume":"154","author":"Jung","year":"2024","journal-title":"J. Allergy Clin. Immunol."},{"issue":"2","key":"10.1016\/j.rmed.2025.108333_bib20","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.rmed.2011.07.021","article-title":"Cardiovascular disease in asthma and COPD: a population-based retrospective cross-sectional study","volume":"106","author":"Cazzola","year":"2012","journal-title":"Respir. Med."},{"issue":"2","key":"10.1016\/j.rmed.2025.108333_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0193143","article-title":"Chronic pbstructive pulmonary disease (COPD) as a disease of early aging: evidence from the EpiChron cohort","volume":"13","author":"Divo","year":"2018","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.rmed.2025.108333_bib22","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1164\/rccm.201201-0034OC","article-title":"Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease","volume":"186","author":"Divo","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"6","key":"10.1016\/j.rmed.2025.108333_bib23","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1016\/j.chest.2021.01.020","article-title":"COPD comorbidity profiles and 2-year trajectory of acute and postacute care use","volume":"159","author":"Shen","year":"2021","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.rmed.2025.108333_bib24","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01269-2018","article-title":"Treatable traits in bronchiectasis","volume":"52","author":"Boaventura","year":"2018","journal-title":"Eur. Respir. J."},{"issue":"8","key":"10.1016\/j.rmed.2025.108333_bib25","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1007\/s10875-023-01593-6","article-title":"Respiratory comorbidities associated with bronchiectasis in patients with common variable immunodeficiency in the USIDNET registry","volume":"43","author":"Correa-Jimenez","year":"2023","journal-title":"J. Clin. Immunol."},{"issue":"1","key":"10.1016\/j.rmed.2025.108333_bib26","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1164\/rccm.202403-0473PP","article-title":"The precision medicine era of bronchiectasis","volume":"210","author":"Chotirmall","year":"2024","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"3","key":"10.1016\/j.rmed.2025.108333_bib27","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00328-2018","article-title":"The overlap between bronchiectasis and chronic airway diseases: state of the art and future directions","volume":"52","author":"Polverino","year":"2018","journal-title":"Eur. Respir. J."},{"issue":"11","key":"10.1016\/j.rmed.2025.108333_bib28","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.1016\/j.jaip.2021.09.003","article-title":"Asthma and three colinear comorbidities: obesity, OSA, and GERD","volume":"9","author":"Althoff","year":"2021","journal-title":"J. Allergy Clin. Immunol. Pract."},{"issue":"7","key":"10.1016\/j.rmed.2025.108333_bib29","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/cea.14106","article-title":"Comorbidity of atopic diseases and gastro-oesophageal reflux: evidence of a shared cause","volume":"52","author":"Brew","year":"2022","journal-title":"Clin. Exp. Allergy"},{"issue":"6","key":"10.1016\/j.rmed.2025.108333_bib30","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/j.jaci.2024.10.006","article-title":"Gastroesophageal reflux disease, laryngopharyngeal reflux, and vocal cord dysfunction\/inducible laryngeal obstruction-overlapping conditions that affect asthma","volume":"154","author":"Eapen","year":"2024","journal-title":"J. Allergy Clin. Immunol."},{"issue":"3","key":"10.1016\/j.rmed.2025.108333_bib31","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/MCP.0000000000001162","article-title":"Comorbidities and multimorbidity in asthma","volume":"31","author":"Maselli","year":"2025","journal-title":"Curr. Opin. Pulm. Med."},{"key":"10.1016\/j.rmed.2025.108333_bib32","doi-asserted-by":"crossref","unstructured":"Chen Y, Cai H, Ye X, et al. Association of depression, anxiety with asthma outcomes and allergic comorbidities: results from the National Health Interview Survey. J. Affect. Disord. Published online June 12, 2025. doi:10.1016\/j.jad.2025.119677.","DOI":"10.1016\/j.jad.2025.119677"},{"issue":"19","key":"10.1016\/j.rmed.2025.108333_bib33","article-title":"Prevalence of comorbidities in chronic obstructive pulmonary disease patients: a meta-analysis","volume":"96","author":"Yin","year":"2017","journal-title":"Medicine (Baltim.)"},{"issue":"3","key":"10.1016\/j.rmed.2025.108333_bib34","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.ccm.2020.06.002","article-title":"Multimorbidity in patients with chronic obstructive pulmonary disease","volume":"41","author":"Divo","year":"2020","journal-title":"Clin. Chest Med."},{"issue":"5","key":"10.1016\/j.rmed.2025.108333_bib35","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.chest.2016.10.055","article-title":"Adult patients with bronchiectasis: a first look at the US Bronchiectasis Research Registry","volume":"151","author":"Aksamit","year":"2017","journal-title":"Chest"},{"issue":"12","key":"10.1016\/j.rmed.2025.108333_bib36","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S2213-2600(16)30320-4","article-title":"Comorbidities and the risk of mortality in patients with bronchiectasis: an international multicentre cohort study","volume":"4","author":"McDonnell","year":"2016","journal-title":"Lancet Respir. Med."},{"issue":"6","key":"10.1016\/j.rmed.2025.108333_bib37","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/j.jaci.2024.01.027","article-title":"Bronchiectasis and asthma: data from the European Bronchiectasis Registry (EMBARC)","volume":"153","author":"Polverino","year":"2024","journal-title":"J. Allergy Clin. Immunol."},{"issue":"3","key":"10.1016\/j.rmed.2025.108333_bib38","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1001\/jama.2025.2680","article-title":"Non-cystic fibrosis bronchiectasis in adults: a review","volume":"334","author":"Barker","year":"2025","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.rmed.2025.108333_bib39","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/j.jaip.2025.01.023","article-title":"Use of high-dose inhaled corticosteroids and risk of corticosteroid-related adverse events in asthma. Findings from the NORDSTAR cohort","volume":"13","author":"von B\u00fclow","year":"2025","journal-title":"J. Allergy Clin. Immunol. Pract."},{"issue":"6","key":"10.1016\/j.rmed.2025.108333_bib40","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.anai.2016.06.017","article-title":"Inhaled corticosteroids: ocular safety and the hypothalamic-pituitary-adrenal axis","volume":"117","author":"Carr","year":"2016","journal-title":"Ann. Allergy Asthma Immunol."},{"issue":"5","key":"10.1016\/j.rmed.2025.108333_bib41","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1398-9995.2006.01090.x","article-title":"Local oropharyngeal side effects of inhaled corticosteroids in patients with asthma","volume":"61","author":"Buhl","year":"2006","journal-title":"Allergy"},{"issue":"4","key":"10.1016\/j.rmed.2025.108333_bib42","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/s11096-024-01736-8","article-title":"Intraclass comparison of inhaled corticosteroids for the risk of pneumonia in chronic obstructive pulmonary airway disorder: a network meta-analysis and meta-regression","volume":"46","author":"Sridharan","year":"2024","journal-title":"Int. J. Clin. Pharm."},{"issue":"21","key":"10.1016\/j.rmed.2025.108333_bib43","doi-asserted-by":"crossref","first-page":"3362","DOI":"10.3390\/diagnostics13213362","article-title":"Hyperglycaemia and chronic obstructive pulmonary disease","volume":"13","author":"Cazzola","year":"2023","journal-title":"Diagnostics"},{"issue":"5","key":"10.1016\/j.rmed.2025.108333_bib44","article-title":"Dose of inhaled corticosteroid in chronic obstructive pulmonary disease and risks of osteoporosis or fracture - a systematic review and meta-analysis","volume":"19","author":"Kwok","year":"2025","journal-title":"Clin. Res. J"},{"key":"10.1016\/j.rmed.2025.108333_bib45","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/5548746","article-title":"Oral candidal load and oral health status in chronic obstructive pulmonary disease (COPD) patients: a case-cohort study","volume":"2021","author":"Khijmatgar","year":"2021","journal-title":"BioMed Res. Int."},{"issue":"3","key":"10.1016\/j.rmed.2025.108333_bib46","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/MOO.0000000000000153","article-title":"Dysphonia associated with the use of inhaled corticosteroids","volume":"23","author":"Chmielewska","year":"2015","journal-title":"Curr. Opin. Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.rmed.2025.108333_bib47","doi-asserted-by":"crossref","unstructured":"Dettoraki M, Vandorou KT, Tsoukalas D, et al. Ocular manifestations in COPD patients. An underrecognized comorbidity. Respir. Med. Published online August 18, 2025. doi:10.1016\/j.rmed.2025.108313.","DOI":"10.1016\/j.rmed.2025.108313"},{"issue":"2","key":"10.1016\/j.rmed.2025.108333_bib48","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1089\/jamp.2009.0762","article-title":"Prevalence and associated factors of oropharyngeal side effects in users of inhaled corticosteroids in a real-life setting","volume":"23","author":"Molimard","year":"2010","journal-title":"J. Aerosol Med. Pulm. Drug Deliv."},{"issue":"12","key":"10.1016\/j.rmed.2025.108333_bib49","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/S2213-2600(14)70213-9","article-title":"The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo-controlled BLESS trial","volume":"2","author":"Rogers","year":"2014","journal-title":"Lancet Respir. Med."},{"issue":"4","key":"10.1016\/j.rmed.2025.108333_bib50","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1055\/s-0041-1730945","article-title":"Long-term antibiotics in bronchiectasis","volume":"42","author":"Suarez-Cuartin","year":"2021","journal-title":"Semin. Respir. Crit. Care Med."},{"issue":"2","key":"10.1016\/j.rmed.2025.108333_bib51","doi-asserted-by":"crossref","first-page":"174","DOI":"10.4103\/lungindia.lungindia_498_19","article-title":"Expert recommendations on the role of macrolides in chronic respiratory diseases","volume":"38","author":"Dhar","year":"2021","journal-title":"Lung India"},{"issue":"2","key":"10.1016\/j.rmed.2025.108333_bib52","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3390\/jof9020144","article-title":"Systemic antifungal therapy for invasive pulmonary infections","volume":"9","author":"Ben-Ami","year":"2023","journal-title":"J Fungi (Basel)"},{"issue":"4","key":"10.1016\/j.rmed.2025.108333_bib53","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00061-2024","article-title":"Revised ISHAM-ABPA working group clinical practice guidelines for diagnosing, classifying and treating allergic bronchopulmonary aspergillosis\/mycoses","volume":"63","author":"Agarwal","year":"2024","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2025.108333_bib54","doi-asserted-by":"crossref","DOI":"10.4414\/smw.2010.13072","article-title":"Chronic age-related diseases share risk factors: do they share pathophysiological mechanisms and why does that matter?","volume":"140","author":"Probst-Hensch","year":"2010","journal-title":"Swiss Med. Wkly."},{"issue":"6","key":"10.1016\/j.rmed.2025.108333_bib55","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1164\/rccm.202407-1320ST","article-title":"A research agenda to improve outcomes in patients with chronic obstructive pulmonary disease and cardiovascular disease: an official American Thoracic Society research statement","volume":"210","author":"Myers","year":"2024","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"10","key":"10.1016\/j.rmed.2025.108333_bib56","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1136\/thx.2009.130260","article-title":"Systemic inflammation and comorbidity in COPD: a result of 'overspill' of inflammatory mediators from the lungs? Review of the evidence","volume":"65","author":"Sinden","year":"2010","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.rmed.2025.108333_bib57","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s12931-014-0111-4","article-title":"Network medicine analysis of COPD multimorbidities","volume":"15","author":"Grosdidier","year":"2014","journal-title":"Respir. Res."},{"issue":"4","key":"10.1016\/j.rmed.2025.108333_bib58","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1183\/13993003.00763-2015","article-title":"Molecular and clinical diseasome of comorbidities in exacerbated COPD patients","volume":"46","author":"Faner","year":"2015","journal-title":"Eur. Respir. J."},{"issue":"3","key":"10.1016\/j.rmed.2025.108333_bib59","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1183\/09031936.00171614","article-title":"COPD comorbidities network","volume":"46","author":"Divo","year":"2015","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2025.108333_bib60","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.phrs.2018.10.008","article-title":"Relationship between diabetes and respiratory diseases - clinical and therapeutic aspects","volume":"137","author":"Visca","year":"2018","journal-title":"Pharmacol. Res."},{"issue":"3","key":"10.1016\/j.rmed.2025.108333_bib61","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jacc.2022.08.754","article-title":"ACC expert consensus decision pathway for integrating atherosclerotic cardiovascular disease and multimorbidity treatment: a framework for pragmatic, patient-centered care: a report of the American College of Cardiology Solution Set Oversight Committee","volume":"81","author":"Birtcher","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1 Suppl 1","key":"10.1016\/j.rmed.2025.108333_bib62","first-page":"S59","article-title":"4. Comprehensive medical evaluation and assessment of comorbidities: standards of care in diabetes - 2025","volume":"48","year":"2025","journal-title":"Diabetes Care"},{"key":"10.1016\/j.rmed.2025.108333_bib63","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.pupt.2018.08.005","article-title":"A proposed scheme to cope with comorbidities in asthma","volume":"52","author":"Marques de Mello","year":"2018","journal-title":"Pulm. Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.rmed.2025.108333_bib64","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1183\/23120541.00215-2022","article-title":"Multidisciplinary care in chronic airway diseases: the Newcastle model","volume":"8","author":"McDonald","year":"2022","journal-title":"ERJ Open Res"},{"issue":"1","key":"10.1016\/j.rmed.2025.108333_bib65","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/MCP.0000000000000640","article-title":"The impact of comorbidities on severe asthma","volume":"26","author":"Rogliani","year":"2020","journal-title":"Curr. Opin. Pulm. Med."},{"issue":"1","key":"10.1016\/j.rmed.2025.108333_bib66","doi-asserted-by":"crossref","first-page":"8105","DOI":"10.1038\/s41598-022-12103-w","article-title":"Additive effects of coexisting respiratory comorbidities on overall or respiratory mortality in patients with asthma: a national cohort study","volume":"12","author":"Yeo","year":"2022","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.rmed.2025.108333_bib67","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1080\/02770903.2017.1306546","article-title":"Mood disorders in adult asthma phenotypes","volume":"55","author":"Labor","year":"2018","journal-title":"J. Asthma"},{"issue":"3","key":"10.1016\/j.rmed.2025.108333_bib68","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/MCP.0000000000000569","article-title":"Bronchiectasis phenotypes","volume":"25","author":"Chang-Macchiu","year":"2019","journal-title":"Curr. Opin. Pulm. Med."},{"issue":"7","key":"10.1016\/j.rmed.2025.108333_bib69","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.3390\/ijms22073340","article-title":"Asthma and chronic rhinosinusitis: how similar are they in pathogenesis and treatment responses?","volume":"22","author":"Matucci","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.rmed.2025.108333_bib70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaci.2019.05.031","article-title":"Phenotypes and endotypes of adult asthma: moving toward precision medicine","volume":"144","author":"Kaur","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"issue":"2","key":"10.1016\/j.rmed.2025.108333_bib71","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.chest.2021.09.036","article-title":"Asthma-COPD overlap: what are the important questions?","volume":"161","author":"Leung","year":"2022","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.rmed.2025.108333_bib72","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1164\/rccm.202108-1943OC","article-title":"Endotyping chronic obstructive pulmonary disease, bronchiectasis, and the \"chronic obstructive pulmonary disease-bronchiectasis association\"","volume":"206","author":"Huang","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"5","key":"10.1016\/j.rmed.2025.108333_bib73","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.3390\/biomedicines12051047","article-title":"First report of the prevalence at baseline and after 1-year follow-up of treatable traits in interstitial lung diseases","volume":"12","author":"Amati","year":"2024","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.rmed.2025.108333_bib74","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41533-020-0172-4","article-title":"Patient perspectives on how to optimise benefits from a breathlessness service for people with COPD","volume":"30","author":"Luckett","year":"2020","journal-title":"NPJ Prim Care Respir Med"},{"issue":"1","key":"10.1016\/j.rmed.2025.108333_bib75","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/s12931-023-02554-8","article-title":"Walking the path of treatable traits in interstitial lung diseases","volume":"24","author":"Amati","year":"2023","journal-title":"Respir. Res."},{"issue":"7","key":"10.1016\/j.rmed.2025.108333_bib76","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1111\/all.13370","article-title":"Comorbid \"treatable traits\" in difficult asthma: current evidence and clinical evaluation","volume":"73","author":"Tay","year":"2018","journal-title":"Allergy"},{"issue":"6","key":"10.1016\/j.rmed.2025.108333_bib77","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00861-2024","article-title":"Integrating hot topics and implementation of treatable traits in asthma","volume":"64","author":"Gibson","year":"2024","journal-title":"Eur. Respir. J."},{"issue":"12","key":"10.1016\/j.rmed.2025.108333_bib78","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1111\/resp.14610","article-title":"The treatable traits approach to adults with obstructive airways disease in primary and secondary care","volume":"28","author":"Thomas","year":"2023","journal-title":"Respirology"},{"issue":"4","key":"10.1016\/j.rmed.2025.108333_bib79","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.anai.2022.02.005","article-title":"Should we apply a treatable traits approach to asthma care?","volume":"128","author":"Melhorn","year":"2022","journal-title":"Ann. Allergy Asthma Immunol."},{"issue":"3","key":"10.1016\/j.rmed.2025.108333_bib80","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01509-2019","article-title":"Targeting treatable traits in severe asthma: a randomised controlled trial","volume":"55","author":"McDonald","year":"2020","journal-title":"Eur. Respir. J."},{"issue":"9","key":"10.1016\/j.rmed.2025.108333_bib81","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1111\/resp.14556","article-title":"Treatable traits, combination inhaler therapy and the future of asthma management","volume":"28","author":"Gibson","year":"2023","journal-title":"Respirology"},{"issue":"7","key":"10.1016\/j.rmed.2025.108333_bib82","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jaip.2025.05.002","article-title":"Treatable traits as a pathway to remission in asthma","volume":"13","author":"Farinha","year":"2025","journal-title":"J. Allergy Clin. Immunol. Pract."},{"issue":"1","key":"10.1016\/j.rmed.2025.108333_bib83","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/MCP.0000000000000445","article-title":"Treatable traits of chronic airways disease","volume":"24","author":"Fingleton","year":"2018","journal-title":"Curr. Opin. Pulm. Med."},{"issue":"11","key":"10.1016\/j.rmed.2025.108333_bib84","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.3390\/cells10113263","article-title":"Treatable traits in chronic respiratory disease: a comprehensive review","volume":"10","author":"Lee","year":"2021","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.rmed.2025.108333_bib85","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1056\/NEJMra2202819","article-title":"Bronchiectasis - A clinical review","volume":"387","author":"O'Donnell","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.rmed.2025.108333_bib86","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00518-2024","article-title":"Bronchiectasis management in adults: state of the art and future directions","volume":"63","author":"Choi","year":"2024","journal-title":"Eur. Respir. J."},{"issue":"4","key":"10.1016\/j.rmed.2025.108333_bib87","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1183\/09031936.00121308","article-title":"Influence of comorbid conditions on asthma","volume":"33","author":"Boulet","year":"2009","journal-title":"Eur. Respir. J."},{"issue":"3","key":"10.1016\/j.rmed.2025.108333_bib88","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.jaip.2023.01.011","article-title":"Treatable traits in airway disease: from theory to practice","volume":"11","author":"Agusti","year":"2023","journal-title":"J. Allergy Clin. Immunol. Pract."},{"issue":"6","key":"10.1016\/j.rmed.2025.108333_bib89","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1159\/000507228","article-title":"The link between asthma and bronchiectasis: state of the art","volume":"99","author":"Crimi","year":"2020","journal-title":"Respiration"},{"key":"10.1016\/j.rmed.2025.108333_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2025.107957","article-title":"Challenges in treating patients with comorbid asthma and bronchiectasis","volume":"238","author":"Cazzola","year":"2025","journal-title":"Respir. Med."},{"key":"10.1016\/j.rmed.2025.108333_bib91","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.2147\/COPD.S508281","article-title":"Treatable traits in patients with obstructive lung diseases in a well-established Asthma\/COPD Service for primary care","volume":"20","author":"Dijk","year":"2025","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"issue":"1","key":"10.1016\/j.rmed.2025.108333_bib92","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00240-2020","article-title":"Identification of asthma phenotypes based on extrapulmonary treatable traits","volume":"57","author":"Freitas","year":"2021","journal-title":"Eur. Respir. J."},{"issue":"6","key":"10.1016\/j.rmed.2025.108333_bib93","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1159\/000529406","article-title":"Multimorbidity patterns in older adults: the role of social variables and lifestyle behaviors","volume":"69","author":"Caballero","year":"2023","journal-title":"Gerontology"},{"issue":"11","key":"10.1016\/j.rmed.2025.108333_bib94","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1004310","article-title":"Sociodemographic characteristics and longitudinal progression of multimorbidity: a multistate modelling analysis of a large primary care records dataset in England","volume":"20","author":"Chen","year":"2023","journal-title":"PLoS Med."},{"issue":"2","key":"10.1016\/j.rmed.2025.108333_bib95","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00442-2023","article-title":"European Respiratory Society statement on frailty in adults with chronic lung disease","volume":"62","author":"Osadnik","year":"2023","journal-title":"Eur. Respir. J."},{"issue":"4","key":"10.1016\/j.rmed.2025.108333_bib96","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.chest.2024.05.027","article-title":"Translating the interplay of cognition and physical performance in COPD and interstitial lung disease: meeting report and literature review","volume":"166","author":"Rozenberg","year":"2024","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2025.108333_bib97","doi-asserted-by":"crossref","DOI":"10.1177\/20406223231171556","article-title":"Cardiovascular diseases or type 2 diabetes mellitus and chronic airway diseases: mutual pharmacological interferences","volume":"14","author":"Cazzola","year":"2023","journal-title":"Ther Adv Chronic Dis"},{"issue":"10","key":"10.1016\/j.rmed.2025.108333_bib98","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1007\/s40265-024-02086-5","article-title":"Asthma and cardiovascular diseases: navigating mutual pharmacological interferences","volume":"84","author":"Cazzola","year":"2024","journal-title":"Drugs"},{"issue":"6","key":"10.1016\/j.rmed.2025.108333_bib99","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1080\/1744666X.2025.2514607","article-title":"The interplay between asthma and type 2 diabetes mellitus: mutual interactions and therapeutic implications","volume":"21","author":"Cazzola","year":"2025","journal-title":"Expet Rev. Clin. Immunol."},{"issue":"14","key":"10.1016\/j.rmed.2025.108333_bib100","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1007\/s40265-022-01785-1","article-title":"Inhaled corticosteroids in adults with non-cystic fibrosis bronchiectasis: from bench to bedside. A narrative review","volume":"82","author":"Mart\u00ednez-Garc\u00eda","year":"2022","journal-title":"Drugs"},{"issue":"173","key":"10.1016\/j.rmed.2025.108333_bib101","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0038-2024","article-title":"Infection and the microbiome in bronchiectasis","volume":"33","author":"Mac Aog\u00e1in","year":"2024","journal-title":"Eur. Respir. Rev."},{"issue":"7","key":"10.1016\/j.rmed.2025.108333_bib102","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1080\/14740338.2024.2362817","article-title":"An overview of the efficacy and safety of \u03b22-adrenoceptor antagonists for the treatment of chronic obstructive pulmonary disease","volume":"23","author":"Matera","year":"2024","journal-title":"Expet Opin. Drug Saf."},{"issue":"7","key":"10.1016\/j.rmed.2025.108333_bib103","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s40265-017-0731-3","article-title":"Management of chronic obstructive pulmonary disease in patients with cardiovascular diseases","volume":"77","author":"Cazzola","year":"2017","journal-title":"Drugs"},{"key":"10.1016\/j.rmed.2025.108333_bib104","doi-asserted-by":"crossref","unstructured":"Cazzola M, Hanania NA, Matera MG, Rogliani P. Biologics for severe asthma: deciphering what is best for the patient. Expet Rev. Clin. Immunol. Published online June 30, 2025. doi:10.1080\/1744666X.2025.2525443.","DOI":"10.1080\/1744666X.2025.2525443"},{"issue":"2","key":"10.1016\/j.rmed.2025.108333_bib105","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1080\/14712598.2022.2160238","article-title":"Biologic therapies for chronic obstructive pulmonary disease","volume":"23","author":"Matera","year":"2023","journal-title":"Expet Opin. Biol. Ther."},{"key":"10.1016\/j.rmed.2025.108333_bib106","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1631321","article-title":"Exploring dupilumab for asthma: from mechanistic insights to clinical outcomes, safety, and cost-effectiveness","volume":"16","author":"Ameer","year":"2025","journal-title":"Front. Pharmacol."},{"issue":"24","key":"10.1016\/j.rmed.2025.108333_bib107","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1056\/NEJMoa2401304","article-title":"Dupilumab for COPD with blood eosinophil evidence of type 2 inflammation","volume":"390","author":"Bhatt","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.rmed.2025.108333_bib108","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ejim.2024.05.011","article-title":"Towards precision medicine in COPD: targeting type 2 cytokines and alarmins","volume":"125","author":"Varricchi","year":"2024","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.rmed.2025.108333_bib109","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/B978-0-12-404717-4.00004-4","article-title":"The biology of thymic stromal lymphopoietin (TSLP)","volume":"66","author":"Ziegler","year":"2013","journal-title":"Adv. Pharmacol."},{"issue":"1","key":"10.1016\/j.rmed.2025.108333_bib110","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S2213-2600(24)00324-2","article-title":"Efficacy and safety of tezepelumab versus placebo in adults with moderate to very severe chronic obstructive pulmonary disease (COURSE): a randomised, placebo-controlled, phase 2a trial","volume":"13","author":"Singh","year":"2025","journal-title":"Lancet Respir. Med."},{"issue":"3","key":"10.1016\/j.rmed.2025.108333_bib111","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.arbres.2022.12.008","article-title":"Biologics in bronchiectasis: a future treatment?","volume":"59","author":"Nigro","year":"2023","journal-title":"Arch. Bronconeumol."},{"key":"10.1016\/j.rmed.2025.108333_bib112","doi-asserted-by":"crossref","unstructured":"Oscullo G, G\u00f3mez-Olivas JD, Martinez-Garcia MA, Present and future of biological treatments in bronchiectasis. Open Respiratory Archives. Published online July 31, 2025. doi:10.1016\/j.opresp.2025.100473.","DOI":"10.1016\/j.opresp.2025.100473"},{"issue":"22","key":"10.1016\/j.rmed.2025.108333_bib113","doi-asserted-by":"crossref","first-page":"6913","DOI":"10.3390\/jcm13226913","article-title":"Assessing the impact of new technologies on managing chronic respiratory diseases","volume":"13","author":"Gra\u00f1a-Castro","year":"2024","journal-title":"J. Clin. Med."},{"issue":"13","key":"10.1016\/j.rmed.2025.108333_bib114","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.7150\/ijms.58191","article-title":"Artificial intelligence and machine learning in chronic airway diseases: focus on asthma and chronic obstructive pulmonary disease","volume":"18","author":"Feng","year":"2021","journal-title":"Int. J. Med. Sci."},{"issue":"5","key":"10.1016\/j.rmed.2025.108333_bib115","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1109\/JBHI.2021.3135838","article-title":"Review of artificial intelligence techniques in chronic obstructive lung disease","volume":"26","author":"Exarchos","year":"2022","journal-title":"IEEE J Biomed Health Inform"},{"key":"10.1016\/j.rmed.2025.108333_bib116","doi-asserted-by":"crossref","unstructured":"Gogali A, Kyriakopoulos C, Potonos D, Ladias A, Tatsis K, Kostikas K. Artificial intelligence in asthma: current status, opportunities, and pitfalls. J. Allergy Clin. Immunol. Pract. Published online June 3, 2025. doi:10.1016\/j.jaip.2025.05.044.","DOI":"10.1016\/j.jaip.2025.05.044"}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611125003968?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611125003968?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:06:01Z","timestamp":1761116761000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611125003968"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":115,"alternative-id":["S0954611125003968"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2025.108333","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comorbidities as treatable traits of chronic airway diseases","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2025.108333","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108333"}}